Fresh From the Bench: Latest Federal Circuit Court Cases
Contributed by Schwabe Williamson & Wyatt. Originally published on Patexia; republished here as part of the LexDana archive.
CASE OF THE WEEK
Natural Alternatives International, Inc. v. Iancu, Appeal No. 2017-1962 (Fed. Cir. Oct. 1, 2018)
In an appeal from an inter partes reexamination, the Federal Circuit affirmed the Board’s determination that the challenged claims were anticipated by or obvious over cited prior art. The claims were directed to increasing athletes’ endurance.
Natural Alternatives International, Inc. (“NAI”) filed a chain of eight patent applications, the earliest of which had a 1997 priority date. Each of the continuing applications included a priority benefit statement under 35 U.S.C. § 120, claiming priority to the first application. On November 18, 2003, NAI filed the fifth application, a continuation-in-part, that claimed priority to the first four applications and a 2003 provisional application. While the fifth application was pending, NAI filed its sixth application on August 29, 2008, claiming priority through the fifth application back to the filing date of the 1997 parent application. However, on September 2, 2008—just four days after filing the sixth application—NAI amended the fifth application to delete priority claims to the first four applications. Thus, while the fifth application only claimed priority to a 2003 provisional application, the sixth through eighth applications still claimed priority through the fifth application to the 1997 priority date.
Written by: Scott Eads and Nika F. Aldrich, Schwabe, Williamson & Wyatt
Contributor: Angela Addae
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…